Walvax Biotechnology Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Runsheng Jiang

Chief Executive Officer (CEO)

CN¥3.7m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	8yrs
Participación del CEO	0.06%
Permanencia media de la dirección	6.8yrs
Promedio de permanencia en la Junta Directiva	3.8yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Runsheng Jiang (67 yo)

8yrs

Permanencia

CN¥3,724,200

Compensación

Mr. Runsheng Jiang serves as Director of Walvax Biotechnology Co., Ltd. since June 22, 2016 and serves as its President and served its Non-Independent Director.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Runsheng Jiang	Director & President	no data	CN¥3.72m	0.058% CN¥ 10.4m
Hua Zhou	Chief Financial Officer	10yrs	CN¥3.41m	0.048% CN¥ 8.5m
Yun Yan Wu	Director of Operations	6.7yrs	CN¥1.85m	sin datos
Jin Long Zhao	Chief Investment Officer	6.7yrs	CN¥1.87m	sin datos
Lin Yuan	Technical Director	6.9yrs	CN¥2.61m	sin datos
Wei Yao	Marketing Director	7.8yrs	CN¥2.53m	sin datos
Qing Gongsun	Director of Human Resources	6.9yrs	CN¥1.77m	0.050% CN¥ 9.0m
Jiankang Zhang	VP & Director	no data	CN¥2.38m	sin datos
Shao Zhong Dong	VP & Director	no data	CN¥2.53m	sin datos
Yu Ran Liu	Board Secretary	1.7yrs	CN¥1.46m	sin datos
Qingtang Duan	Engineering Director	less than a year	CN¥1.38m	sin datos

6.8yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300142 es experimentado (6.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Runsheng Jiang	Director & President	8yrs	CN¥3.72m	0.058% CN¥ 10.4m
Jiankang Zhang	VP & Director	4.1yrs	CN¥2.38m	sin datos
Shao Zhong Dong	VP & Director	2.4yrs	CN¥2.53m	sin datos
Yunchun Li	Chairman	15yrs	CN¥4.33m	1.7% CN¥ 302.2m
Zhen Huang	Vice Chairman	7.1yrs	CN¥5.56m	1.11% CN¥ 197.0m
Jianmei Zhao	Independent Director	3.8yrs	CN¥114.60k	sin datos
Shiqing Ding	Chairwoman of the Supervisory Board	3.8yrs	sin datos	sin datos
Yongwu Fan	Non-Independent Director	3.8yrs	CN¥83.70k	sin datos
Ting Yan	Director	2.6yrs	CN¥333.40k	0.0044% CN¥ 778.7k
Jinyu Zhu	Independent Director	1.7yrs	CN¥114.60k	sin datos
Ganghong Sun	Independent Director	1.7yrs	CN¥114.60k	sin datos
Lingbing Zeng	Independent Director	1.7yrs	CN¥114.60k	sin datos

3.8yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de 300142 se considera experimentada (3.8 años de antigüedad promedio).

Walvax Biotechnology Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Walvax Biotechnology Co., Ltd., Annual General Meeting, Apr 19, 2024

Less than half of directors are independent

Walvax Biotechnology Co., Ltd. Announces Executive Appointments

Walvax Biotechnology Co., Ltd., Annual General Meeting, Apr 12, 2022

Recent updates

Walvax Biotechnology Co., Ltd. Implements Final Cash Dividend for the Year 2023, Payable on 30 May 2024

First quarter 2024 earnings released: EPS: CN¥0.009 (vs CN¥0.11 in 1Q 2023)

Walvax Biotechnology Co., Ltd., Annual General Meeting, Apr 19, 2024

Full year 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.46 in FY 2022)

Walvax Biotechnology Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment deteriorates as stock falls 16%

Walvax Biotechnology Co., Ltd. to Report Fiscal Year 2023 Results on Mar 27, 2024

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: CN¥0.061 (vs CN¥0.073 in 3Q 2022)

Walvax Biotechnology Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Second quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.24 in 2Q 2022)

Walvax Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 11, 2023

Full year 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.27 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.073 (vs CN¥0.029 in 3Q 2021)

Walvax Biotechnology Co., Ltd. Announces Executive Appointments

Walvax Biotechnology Co., Ltd. announced that it expects to receive CNY 1.2 billion in funding

Second quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.18 in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.024 (vs CN¥0.021 in 1Q 2021)

Walvax Biotechnology Co., Ltd. Approves Cash Dividend for 2021

Walvax Biotechnology Co., Ltd., Annual General Meeting, Apr 12, 2022

Third quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.24 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.052 in 2Q 2020)

Walvax Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 19, 2021

First quarter 2021 earnings released: EPS CN¥0.021 (vs CN¥0.012 loss in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.65 (vs CN¥0.092 in FY 2019)

Walvax Biotechnology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day low: CN¥36.53

New 90-day low: CN¥48.42

New 90-day low: CN¥48.82

Third quarter earnings released

Walvax Biotechnology Co., Ltd. to Report Q3, 2020 Results on Oct 21, 2020

New 90-day low: CN¥50.88

Earnings released

New 90-day high - CN¥91.80

Walvax Biotechnology Co., Ltd. to Report First Half, 2020 Results on Aug 15, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad